IRadimed Corporation (IRMD)

Market Cap	530.57M
Revenue (ttm)	65.56M
Net Income (ttm)	17.19M
Shares Out	12.66M
EPS (ttm)	1.35
PE Ratio	31.04
Forward PE	26.85
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,532
Open	42.57
Previous Close	42.36
Day's Range	41.53 - 42.88
52-Week Range	36.12 - 51.04
Beta	0.86
Analysts	Strong Buy
Price Target	65.00 (+55.13%)
Earnings Date	May 6, 2024

About IRMD

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump mo...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 16, 2014
• Employees: 148
• Stock Exchange: NASDAQ
• Ticker Symbol: IRMD

Financial Performance

In 2023, IRadimed's revenue was $65.56 million, an increase of 23.00% compared to the previous year's $53.30 million. Earnings were $17.19 million, an increase of 34.02%.

Analyst Forecast

According to one analyst, the rating for IRMD stock is "Strong Buy" and the 12-month stock price forecast is $65.0.

Price Target

$65.0

(55.13% upside)

Analyst Consensus: Strong Buy